Starpharma Holdings Ltd (SPL) - Total Liabilities

Latest as of December 2025: AU$4.69 Million AUD ≈ $3.32 Million USD

Based on the latest financial reports, Starpharma Holdings Ltd (SPL) has total liabilities worth AU$4.69 Million AUD (≈ $3.32 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore SPL operating cash flow to assess how effectively this company generates cash.

Starpharma Holdings Ltd - Total Liabilities Trend (2000–2025)

This chart illustrates how Starpharma Holdings Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Starpharma Holdings Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

Starpharma Holdings Ltd Competitors by Total Liabilities

The table below lists competitors of Starpharma Holdings Ltd ranked by their total liabilities.

Company Country Total Liabilities
Kore Potash Plc
AU:KP2
Australia AU$453.96K
Creative Sensor Inc
TW:8249
Taiwan NT$2.45 Billion
Blue Acquisition Corp. Class A Ordinary Shares
NASDAQ:BACC
USA $8.12 Million
PTC India Financial Services Limited
NSE:PFS
India Rs23.73 Billion
Virginia National Bankshares Corp
NASDAQ:VABK
USA $1.47 Billion
Red Hill Minerals Ltd
AU:RHI
Australia AU$10.26 Million
Innowireless Co. Ltd
KQ:073490
Korea ₩52.47 Billion
Exel Industries
PA:EXE
France €472.14 Million

Liability Composition Analysis (2000–2025)

This chart breaks down Starpharma Holdings Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SPL market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 5.26 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 3.96 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.22 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.18 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Starpharma Holdings Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Starpharma Holdings Ltd (2000–2025)

The table below shows the annual total liabilities of Starpharma Holdings Ltd from 2000 to 2025.

Year Total Liabilities Change
2025-06-30 AU$6.42 Million
≈ $4.54 Million
-26.16%
2024-06-30 AU$8.70 Million
≈ $6.15 Million
-49.64%
2023-06-30 AU$17.27 Million
≈ $12.22 Million
-2.87%
2022-06-30 AU$17.78 Million
≈ $12.58 Million
+62.57%
2021-06-30 AU$10.94 Million
≈ $7.74 Million
+41.10%
2020-06-30 AU$7.75 Million
≈ $5.49 Million
+19.93%
2019-06-30 AU$6.46 Million
≈ $4.57 Million
+23.50%
2018-06-30 AU$5.23 Million
≈ $3.70 Million
-6.65%
2017-06-30 AU$5.61 Million
≈ $3.97 Million
-41.68%
2016-06-30 AU$9.62 Million
≈ $6.80 Million
+40.88%
2015-06-30 AU$6.83 Million
≈ $4.83 Million
+74.51%
2014-06-30 AU$3.91 Million
≈ $2.77 Million
+51.47%
2013-06-30 AU$2.58 Million
≈ $1.83 Million
-54.03%
2012-06-30 AU$5.62 Million
≈ $3.97 Million
+165.70%
2011-06-30 AU$2.11 Million
≈ $1.50 Million
-22.37%
2010-06-30 AU$2.72 Million
≈ $1.93 Million
-18.67%
2009-06-30 AU$3.35 Million
≈ $2.37 Million
-21.59%
2008-06-30 AU$4.27 Million
≈ $3.02 Million
-9.14%
2007-06-30 AU$4.70 Million
≈ $3.33 Million
+27.11%
2006-06-30 AU$3.70 Million
≈ $2.62 Million
+45.91%
2005-06-30 AU$2.53 Million
≈ $1.79 Million
+182.02%
2004-06-30 AU$898.45K
≈ $635.71K
-38.98%
2003-06-30 AU$1.47 Million
≈ $1.04 Million
-7.58%
2002-06-30 AU$1.59 Million
≈ $1.13 Million
+43.55%
2001-06-30 AU$1.11 Million
≈ $785.26K
+456.90%
2000-06-30 AU$199.28K
≈ $141.00K
--

About Starpharma Holdings Ltd

AU:SPL Australia Biotechnology
Market Cap
$215.93 Million
AU$305.17 Million AUD
Market Cap Rank
#16278 Global
#464 in Australia
Share Price
AU$0.73
Change (1 day)
-2.03%
52-Week Range
AU$0.09 - AU$0.75
All Time High
AU$2.49
About

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally. The company's products include VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurr… Read more